Annual EBIT
-$566.93 M
-$70.31 M-14.16%
31 December 2023
Summary:
PTC Therapeutics annual earnings before interest & taxes is currently -$566.93 million, with the most recent change of -$70.31 million (-14.16%) on 31 December 2023. During the last 3 years, it has fallen by -$220.35 million (-63.58%). PTCT annual EBIT is now -1953.80% below its all-time high of $33.45 million.PTCT EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$56.38 M
-$14.14 M-33.47%
30 September 2024
Summary:
PTC Therapeutics quarterly earnings before interest & taxes is currently -$56.38 million, with the most recent change of -$14.14 million (-33.47%) on 30 September 2024. Over the past year, it has increased by +$82.05 million (+59.27%). PTCT quarterly EBIT is now -1134.53% below its all-time high of $5.45 million, reached on 31 December 2017.PTCT Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$255.26 M
+$82.05 M+24.32%
30 September 2024
Summary:
PTC Therapeutics TTM earnings before interest & taxes is currently -$255.26 million, with the most recent change of +$82.05 million (+24.32%) on 30 September 2024. Over the past year, it has increased by +$364.08 million (+58.79%). PTCT TTM EBIT is now -4035.35% below its all-time high of -$6.17 million, reached on 31 March 2012.PTCT TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PTCT EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -14.2% | +59.3% | +58.8% |
| 3 y3 years | -63.6% | +49.6% | +27.8% |
| 5 y5 years | -390.6% | +2.2% | -21.1% |
PTCT EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -63.6% | at low | -33.5% | +72.9% | at high | +58.8% |
| 5 y | 5 years | -390.6% | at low | -113.8% | +72.9% | -21.1% | +58.8% |
| alltime | all time | -1953.8% | at low | -1134.5% | +72.9% | -4035.3% | +58.8% |
PTC Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$56.38 M(+33.5%) | -$255.26 M(-24.3%) |
| June 2024 | - | -$42.24 M(-3.7%) | -$337.31 M(-33.0%) |
| Mar 2024 | - | -$43.86 M(-61.1%) | -$503.13 M(-11.3%) |
| Dec 2023 | -$566.93 M(+14.2%) | -$112.78 M(-18.5%) | -$566.93 M(-8.5%) |
| Sept 2023 | - | -$138.43 M(-33.5%) | -$619.35 M(+5.5%) |
| June 2023 | - | -$208.06 M(+93.3%) | -$587.24 M(+16.1%) |
| Mar 2023 | - | -$107.66 M(-34.8%) | -$505.90 M(+1.9%) |
| Dec 2022 | -$496.62 M(+14.9%) | -$165.19 M(+55.4%) | -$496.62 M(+11.0%) |
| Sept 2022 | - | -$106.33 M(-16.1%) | -$447.53 M(-1.2%) |
| June 2022 | - | -$126.72 M(+28.8%) | -$453.06 M(+7.4%) |
| Mar 2022 | - | -$98.38 M(-15.3%) | -$421.66 M(-2.5%) |
| Dec 2021 | -$432.32 M(+24.7%) | -$116.11 M(+3.8%) | -$432.32 M(+22.2%) |
| Sept 2021 | - | -$111.86 M(+17.3%) | -$353.64 M(+31.9%) |
| June 2021 | - | -$95.32 M(-12.6%) | -$268.15 M(-23.1%) |
| Mar 2021 | - | -$109.03 M(+191.3%) | -$348.79 M(+0.6%) |
| Dec 2020 | -$346.58 M(+52.4%) | -$37.43 M(+42.0%) | -$346.58 M(-6.5%) |
| Sept 2020 | - | -$26.36 M(-85.0%) | -$370.72 M(-7.8%) |
| June 2020 | - | -$175.96 M(+64.7%) | -$402.03 M(+51.7%) |
| Mar 2020 | - | -$106.82 M(+73.5%) | -$265.01 M(+16.5%) |
| Dec 2019 | -$227.44 M(+96.8%) | -$61.57 M(+6.8%) | -$227.44 M(+7.9%) |
| Sept 2019 | - | -$57.67 M(+48.1%) | -$210.87 M(+4.7%) |
| June 2019 | - | -$38.94 M(-43.8%) | -$201.43 M(+19.9%) |
| Mar 2019 | - | -$69.25 M(+53.9%) | -$168.06 M(+45.4%) |
| Dec 2018 | -$115.56 M | -$45.01 M(-6.7%) | -$115.56 M(+77.5%) |
| Sept 2018 | - | -$48.23 M(+765.3%) | -$65.10 M(+36.3%) |
| June 2018 | - | -$5.57 M(-66.7%) | -$47.76 M(-12.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2018 | - | -$16.74 M(-407.2%) | -$54.68 M(-15.0%) |
| Dec 2017 | -$64.29 M(-51.3%) | $5.45 M(-117.6%) | -$64.29 M(-32.1%) |
| Sept 2017 | - | -$30.89 M(+147.2%) | -$94.74 M(-1.2%) |
| June 2017 | - | -$12.50 M(-52.6%) | -$95.91 M(-20.1%) |
| Mar 2017 | - | -$26.36 M(+5.5%) | -$119.97 M(-9.2%) |
| Dec 2016 | -$132.06 M(-21.0%) | -$24.99 M(-22.1%) | -$132.06 M(-14.9%) |
| Sept 2016 | - | -$32.06 M(-12.3%) | -$155.27 M(-6.1%) |
| June 2016 | - | -$36.56 M(-4.9%) | -$165.44 M(-1.2%) |
| Mar 2016 | - | -$38.44 M(-20.2%) | -$167.50 M(+0.2%) |
| Dec 2015 | -$167.13 M(+68.1%) | -$48.20 M(+14.1%) | -$167.13 M(+10.6%) |
| Sept 2015 | - | -$42.23 M(+9.3%) | -$151.16 M(+10.7%) |
| June 2015 | - | -$38.63 M(+1.5%) | -$136.53 M(+10.8%) |
| Mar 2015 | - | -$38.07 M(+18.1%) | -$123.27 M(+24.0%) |
| Dec 2014 | -$99.41 M(+119.0%) | -$32.23 M(+16.8%) | -$99.41 M(+16.6%) |
| Sept 2014 | - | -$27.60 M(+8.8%) | -$85.28 M(+37.7%) |
| June 2014 | - | -$25.37 M(+78.5%) | -$61.95 M(+21.4%) |
| Mar 2014 | - | -$14.21 M(-21.5%) | -$51.03 M(+12.4%) |
| Dec 2013 | -$45.40 M(+69.3%) | -$18.09 M(+323.1%) | -$45.40 M(+36.2%) |
| Sept 2013 | - | -$4.28 M(-70.4%) | -$33.34 M(-7.7%) |
| June 2013 | - | -$14.45 M(+68.5%) | -$36.12 M(+31.8%) |
| Mar 2013 | - | -$8.58 M(+42.1%) | -$27.40 M(+9.6%) |
| Dec 2012 | -$26.81 M(-187.7%) | -$6.03 M(-14.5%) | -$25.00 M(+31.8%) |
| Sept 2012 | - | -$7.06 M(+23.1%) | -$18.96 M(+59.3%) |
| June 2012 | - | -$5.73 M(-7.1%) | -$11.91 M(+92.9%) |
| Mar 2012 | - | -$6.17 M | -$6.17 M |
| Dec 2011 | $30.58 M | - | - |
FAQ
- What is PTC Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for PTC Therapeutics?
- What is PTC Therapeutics annual EBIT year-on-year change?
- What is PTC Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for PTC Therapeutics?
- What is PTC Therapeutics quarterly EBIT year-on-year change?
- What is PTC Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for PTC Therapeutics?
- What is PTC Therapeutics TTM EBIT year-on-year change?
What is PTC Therapeutics annual earnings before interest & taxes?
The current annual EBIT of PTCT is -$566.93 M
What is the all time high annual EBIT for PTC Therapeutics?
PTC Therapeutics all-time high annual earnings before interest & taxes is $33.45 M
What is PTC Therapeutics annual EBIT year-on-year change?
Over the past year, PTCT annual earnings before interest & taxes has changed by -$70.31 M (-14.16%)
What is PTC Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of PTCT is -$56.38 M
What is the all time high quarterly EBIT for PTC Therapeutics?
PTC Therapeutics all-time high quarterly earnings before interest & taxes is $5.45 M
What is PTC Therapeutics quarterly EBIT year-on-year change?
Over the past year, PTCT quarterly earnings before interest & taxes has changed by +$82.05 M (+59.27%)
What is PTC Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of PTCT is -$255.26 M
What is the all time high TTM EBIT for PTC Therapeutics?
PTC Therapeutics all-time high TTM earnings before interest & taxes is -$6.17 M
What is PTC Therapeutics TTM EBIT year-on-year change?
Over the past year, PTCT TTM earnings before interest & taxes has changed by +$364.08 M (+58.79%)